English | Español
Patient Daily | Aug 4, 2026

Pfizer announces $2.5 billion in additional cuts to R&D and manufacturing
Patient Daily | Aug 4, 2026

Researchers identify how breast cancer recruits nerves to support tumor growth
Patient Daily | Aug 4, 2026

HIPEC treatment combines surgery and heated chemotherapy for advanced abdominal cancers
Patient Daily | Aug 4, 2026

Study examines birth order and disease risk in over 10 million US siblings
Patient Daily | Aug 4, 2026

UCLA Health study finds GLP-1 therapy may lower fracture risk in type 2 diabetes patients
Patient Daily | Aug 4, 2026

Researchers identify cellular mechanism linked to congenital heart defects
Patient Daily | Aug 4, 2026

Study finds tadalafil may raise glaucoma risk in men with enlarged prostates
Patient Daily | Aug 4, 2026

Vertex CEO says competition supports confidence in upcoming IgA nephropathy drug

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'